Farmers & Merchants Investments Inc Nektar Therapeutics Transaction History

Farmers & Merchants Investments Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$3.04 - $5.14 $343 - $580	113 New	113 $0
Q4 2019 Jan 21, 2020	SELL	$15.87 - $23.12 $1,412 - $2,057	-89 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$31.0 - $36.3 $62 - $72	2 Added 2.3%	89 $3,000
Q1 2019 Apr 26, 2019	BUY	$31.58 - $46.35 $663 - $973	21 Added 31.82%	87 $3,000
Q3 2018 Oct 30, 2018	BUY	$46.46 - $68.49 $325 - $479	7 Added 11.86%	66 $4,000

Q2 2018 Jul 23, 2018	BUY	$46.25 - $104.45 $2,728 - $6,162	59 New	59 $3,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Farmers & Merchants Investments Inc, based on Form 13F filings with the SEC.

Stay updated on Farmers & Merchants Investments Inc with notifications on news.